APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metformin Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metformin Drugs Industry Growth and Trends Forecast to 2032

2 January 2026101 pages

Choose your research edition.

Industry ResearchMetformin Drugs Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Metformin Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Metformin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metformin Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Metformin Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Metformin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metformin Drugs include Alkem, Apotex, Atlas Pharmaceuticals, Bristol-Myers Squibb, Dr. Reddy’s Laboratories, Mallinckrodt, Teva Pharmaceuticals, Torrent Pharmaceuticals and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metformin Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metformin Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metformin Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metformin Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metformin Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metformin Drugs Market by Company

Alkem

Apotex

Atlas Pharmaceuticals

Bristol-Myers Squibb

Dr. Reddy’s Laboratories

Mallinckrodt

Teva Pharmaceuticals

Torrent Pharmaceuticals

Viatris

Novartis

Sun Pharmaceutical Industries

Metformin Drugs Segment by Type

50 Tablets

100 Tablets

Other

Metformin Drugs Segment by Application

Hospital

Drugs Stores

Metformin Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metformin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metformin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50 Tablets Table 2. Major Company of 100 Tablets Table 3. Major Company of Other Table 4. Global Metformin Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Metformin Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Metformin Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Metformin Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Metformin Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Metformin Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Metformin Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Metformin Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Metformin Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Metformin Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Metformin Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Metformin Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Metformin Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Metformin Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Metformin Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Metformin Drugs Industry Trends Table 26. Metformin Drugs Industry Drivers Table 27. Metformin Drugs Industry Opportunities and Challenges Table 28. Metformin Drugs Industry Restraints Table 29. Global Metformin Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Metformin Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Metformin Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Metformin Drugs Sales Share by Company (2021-2026) Table 33. Global Metformin Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Metformin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Metformin Drugs Major Company Production Sites and Headquarters Table 36. Global Metformin Drugs Company, Product Type & Application Table 37. Global Metformin Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Metformin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Metformin Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Metformin Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Metformin Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Metformin Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Metformin Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Metformin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Metformin Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Metformin Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Metformin Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Metformin Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Metformin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Metformin Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Metformin Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Metformin Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Metformin Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Metformin Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Metformin Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Metformin Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Metformin Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Metformin Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Metformin Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Metformin Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Metformin Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Metformin Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Metformin Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Metformin Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Alkem Company Information Table 73. Alkem Business Overview Table 74. Alkem Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Alkem Metformin Drugs Product Portfolio Table 76. Alkem Recent Development Table 77. Apotex Company Information Table 78. Apotex Business Overview Table 79. Apotex Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apotex Metformin Drugs Product Portfolio Table 81. Apotex Recent Development Table 82. Atlas Pharmaceuticals Company Information Table 83. Atlas Pharmaceuticals Business Overview Table 84. Atlas Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Atlas Pharmaceuticals Metformin Drugs Product Portfolio Table 86. Atlas Pharmaceuticals Recent Development Table 87. Bristol-Myers Squibb Company Information Table 88. Bristol-Myers Squibb Business Overview Table 89. Bristol-Myers Squibb Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bristol-Myers Squibb Metformin Drugs Product Portfolio Table 91. Bristol-Myers Squibb Recent Development Table 92. Dr. Reddy’s Laboratories Company Information Table 93. Dr. Reddy’s Laboratories Business Overview Table 94. Dr. Reddy’s Laboratories Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio Table 96. Dr. Reddy’s Laboratories Recent Development Table 97. Mallinckrodt Company Information Table 98. Mallinckrodt Business Overview Table 99. Mallinckrodt Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Mallinckrodt Metformin Drugs Product Portfolio Table 101. Mallinckrodt Recent Development Table 102. Teva Pharmaceuticals Company Information Table 103. Teva Pharmaceuticals Business Overview Table 104. Teva Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Pharmaceuticals Metformin Drugs Product Portfolio Table 106. Teva Pharmaceuticals Recent Development Table 107. Torrent Pharmaceuticals Company Information Table 108. Torrent Pharmaceuticals Business Overview Table 109. Torrent Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Torrent Pharmaceuticals Metformin Drugs Product Portfolio Table 111. Torrent Pharmaceuticals Recent Development Table 112. Viatris Company Information Table 113. Viatris Business Overview Table 114. Viatris Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Viatris Metformin Drugs Product Portfolio Table 116. Viatris Recent Development Table 117. Novartis Company Information Table 118. Novartis Business Overview Table 119. Novartis Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Novartis Metformin Drugs Product Portfolio Table 121. Novartis Recent Development Table 122. Sun Pharmaceutical Industries Company Information Table 123. Sun Pharmaceutical Industries Business Overview Table 124. Sun Pharmaceutical Industries Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sun Pharmaceutical Industries Metformin Drugs Product Portfolio Table 126. Sun Pharmaceutical Industries Recent Development Table 127. North America Metformin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Metformin Drugs Sales Market Share by Country (2021-2026) Table 130. North America Metformin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Metformin Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Metformin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Metformin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Metformin Drugs Market Share by Country (2021-2026) Table 135. North America Metformin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Metformin Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Metformin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 139. Europe Metformin Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Metformin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Metformin Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Metformin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Metformin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Metformin Drugs Market Share by Country (2021-2026) Table 145. Europe Metformin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Metformin Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Metformin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Metformin Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Metformin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Metformin Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Metformin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Metformin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Metformin Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Metformin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Metformin Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Metformin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 159. Latin America Metformin Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Metformin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Metformin Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Metformin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Metformin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Metformin Drugs Market Share by Country (2021-2026) Table 165. Latin America Metformin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Metformin Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Metformin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Metformin Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Metformin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Metformin Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Metformin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Metformin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Metformin Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Metformin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Metformin Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Metformin Drugs Distributors List Table 180. Metformin Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Metformin Drugs Image Figure 2. Global Metformin Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metformin Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Metformin Drugs Sales (2021-2032) & (K Units) Figure 5. 50 Tablets Image Figure 6. Global 50 Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100 Tablets Image Figure 8. Global 100 Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Metformin Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Metformin Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Metformin Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Metformin Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Metformin Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Metformin Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Metformin Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Metformin Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Metformin Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Metformin Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Metformin Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Metformin Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Metformin Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Drugs Stores Image Figure 28. Global Drugs Stores Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Metformin Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Metformin Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Metformin Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Metformin Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Metformin Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Metformin Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Metformin Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Metformin Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Metformin Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Metformin Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Metformin Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Metformin Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Metformin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Metformin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Metformin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Metformin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Metformin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Metformin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Metformin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Metformin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Metformin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Metformin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Metformin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Metformin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Metformin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Metformin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Metformin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Metformin Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Metformin Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 50 Tablets
  • 100 Tablets
  • Other
Applications
  • Hospital
  • Drugs Stores
Companies covered
  • Alkem
  • Apotex
  • Atlas Pharmaceuticals
  • Bristol-Myers Squibb
  • Dr. Reddy’s Laboratories
  • Mallinckrodt
  • Teva Pharmaceuticals
  • Torrent Pharmaceuticals
  • Viatris
  • Novartis
  • Sun Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metformin Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metformin Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metformin Drugs Market by Type
  6. 1.3.1 50 Tablets
  7. 1.3.2 100 Tablets
  8. 1.3.3 Other
  9. 1.4 Global Metformin Drugs Market Size by Type
  10. 1.4.1 Global Metformin Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Metformin Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Metformin Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Metformin Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Metformin Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Metformin Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Metformin Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Metformin Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metformin Drugs Industry Trends
  2. 2.2 Metformin Drugs Industry Drivers
  3. 2.3 Metformin Drugs Industry Opportunities and Challenges
  4. 2.4 Metformin Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metformin Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Metformin Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Metformin Drugs Price (2021-2026)
  4. 3.4 Global Metformin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metformin Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Metformin Drugs Company, Product Type & Application
  7. 3.7 Global Metformin Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metformin Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metformin Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metformin Drugs Tier 1, Tier 2, and Tier 3
4 Metformin Drugs Regional Status and Outlook
  1. 4.1 Global Metformin Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metformin Drugs Historic Market Size by Region
  3. 4.2.1 Global Metformin Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metformin Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metformin Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metformin Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Metformin Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metformin Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metformin Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metformin Drugs by Application
  1. 5.1 Metformin Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Stores
  4. 5.2 Global Metformin Drugs Market Size by Application
  5. 5.2.1 Global Metformin Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Metformin Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Metformin Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Metformin Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Metformin Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Metformin Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Metformin Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Metformin Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alkem
  2. 6.1.1 Alkem Company Information
  3. 6.1.2 Alkem Business Overview
  4. 6.1.3 Alkem Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alkem Metformin Drugs Product Portfolio
  6. 6.1.5 Alkem Recent Developments
  7. 6.2 Apotex
  8. 6.2.1 Apotex Company Information
  9. 6.2.2 Apotex Business Overview
  10. 6.2.3 Apotex Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apotex Metformin Drugs Product Portfolio
  12. 6.2.5 Apotex Recent Developments
  13. 6.3 Atlas Pharmaceuticals
  14. 6.3.1 Atlas Pharmaceuticals Company Information
  15. 6.3.2 Atlas Pharmaceuticals Business Overview
  16. 6.3.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Atlas Pharmaceuticals Metformin Drugs Product Portfolio
  18. 6.3.5 Atlas Pharmaceuticals Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Metformin Drugs Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 Dr. Reddy’s Laboratories
  26. 6.5.1 Dr. Reddy’s Laboratories Company Information
  27. 6.5.2 Dr. Reddy’s Laboratories Business Overview
  28. 6.5.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio
  30. 6.5.5 Dr. Reddy’s Laboratories Recent Developments
  31. 6.6 Mallinckrodt
  32. 6.6.1 Mallinckrodt Company Information
  33. 6.6.2 Mallinckrodt Business Overview
  34. 6.6.3 Mallinckrodt Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mallinckrodt Metformin Drugs Product Portfolio
  36. 6.6.5 Mallinckrodt Recent Developments
  37. 6.7 Teva Pharmaceuticals
  38. 6.7.1 Teva Pharmaceuticals Company Information
  39. 6.7.2 Teva Pharmaceuticals Business Overview
  40. 6.7.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceuticals Metformin Drugs Product Portfolio
  42. 6.7.5 Teva Pharmaceuticals Recent Developments
  43. 6.8 Torrent Pharmaceuticals
  44. 6.8.1 Torrent Pharmaceuticals Company Information
  45. 6.8.2 Torrent Pharmaceuticals Business Overview
  46. 6.8.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Torrent Pharmaceuticals Metformin Drugs Product Portfolio
  48. 6.8.5 Torrent Pharmaceuticals Recent Developments
  49. 6.9 Viatris
  50. 6.9.1 Viatris Company Information
  51. 6.9.2 Viatris Business Overview
  52. 6.9.3 Viatris Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Viatris Metformin Drugs Product Portfolio
  54. 6.9.5 Viatris Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Metformin Drugs Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Sun Pharmaceutical Industries
  62. 6.11.1 Sun Pharmaceutical Industries Company Information
  63. 6.11.2 Sun Pharmaceutical Industries Business Overview
  64. 6.11.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sun Pharmaceutical Industries Metformin Drugs Product Portfolio
  66. 6.11.5 Sun Pharmaceutical Industries Recent Developments
7 North America by Country
  1. 7.1 North America Metformin Drugs Sales by Country
  2. 7.1.1 North America Metformin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metformin Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Metformin Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metformin Drugs Market Size by Country
  6. 7.2.1 North America Metformin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metformin Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Metformin Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metformin Drugs Sales by Country
  2. 8.1.1 Europe Metformin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metformin Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Metformin Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metformin Drugs Market Size by Country
  6. 8.2.1 Europe Metformin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metformin Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metformin Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metformin Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Metformin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metformin Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metformin Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metformin Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Metformin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metformin Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metformin Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metformin Drugs Sales by Country
  2. 10.1.1 South America Metformin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metformin Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Metformin Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metformin Drugs Market Size by Country
  6. 10.2.1 South America Metformin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metformin Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Metformin Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metformin Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Metformin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metformin Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metformin Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metformin Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Metformin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metformin Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metformin Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metformin Drugs Value Chain Analysis
  2. 12.1.1 Metformin Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metformin Drugs Production Mode & Process
  7. 12.2 Metformin Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metformin Drugs Distributors
  10. 12.2.3 Metformin Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst